Our core business lies in the development, production and distribution of high-quality, affordable generic medicines. We offer approximately 1 100 generic compounds worldwide and are a leading provider of differentiated, value-added products, including state-of-the-art biosimilars, injectables, inhalers and transdermal patches.
Our portfolio of medicines includes both blockbusters and niche products for all major therapeutic areas.
At Sandoz, we differentiate ourselves through our broad range of product forms and ability to develop and produce complex, value-added generic products.
Sandoz is the pioneer and undisputed global leader in the rapidly emerging market for biosimilars.
Frequently Asked Questions
Everything you wanted to know about the generics industry.